Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
British Journal of Cancer
|
March 23, 2006
Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking
K Sugio, H Uramoto, K Ono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2013
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors
N Yamamoto, H Murakami, T Nishina, et al.
Scandinavian Cardiovascular Journal : SCJ
|
November 5, 1998
Pulmonary blastoma in an adult. A case with rapid progression
K Ondo, T Ishida, K Yamazaki, et al.
Oncogene
|
February 14, 2007
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines
T Igarashi, H Izumi, T Uchiumi, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
DNA methylation profiles of lung tumors
S Toyooka, K O Toyooka, R Maruyama, et al.
ESMO Open
|
June 21, 2021
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
K Hotta, S Saeki, M Yamaguchi, et al.
ESMO Open
|
April 1, 2026
Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L
T Matsubara, T Sakamoto, T Takahama, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
British Journal of Cancer
|
March 23, 2006
Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking
K Sugio, H Uramoto, K Ono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2013
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors
N Yamamoto, H Murakami, T Nishina, et al.
Scandinavian Cardiovascular Journal : SCJ
|
November 5, 1998
Pulmonary blastoma in an adult. A case with rapid progression
K Ondo, T Ishida, K Yamazaki, et al.
Oncogene
|
February 14, 2007
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines
T Igarashi, H Izumi, T Uchiumi, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
DNA methylation profiles of lung tumors
S Toyooka, K O Toyooka, R Maruyama, et al.
ESMO Open
|
June 21, 2021
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
K Hotta, S Saeki, M Yamaguchi, et al.
ESMO Open
|
April 1, 2026
Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L
T Matsubara, T Sakamoto, T Takahama, et al.
Page
of 12